Received Jul 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 29Z7E | — |
Expired dose administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 65-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 29Z7E, expiry date 01-JUL-2025) for prophylaxis. On 21-JUL-2025, the patient received Arexvy. On 21-JUL-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: Expired dose administered). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 21-JUL-2025 The pharmacist reported that there was a vaccine that was administered today (on the reporting day) and was expired for the vaccine, the diluent was still in date, but the vaccine itself was out of the date, which led to expired vaccine used. The reporter's manager had called to see how viable the vaccine still was and whether the patient needs to get revaccinated.